RxSight, Inc.RXSTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank50
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Percentile
P50
Within normal range
vs 5Y Ago
-1.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-39.64M-66.8%
2024$-23.76M+42.1%
2023$-41.04M+29.0%
2022$-57.78M-40.9%
2021$-41.01M-227.5%
2020$32.15M-75.3%
2019$130.20M-